3Hammock L, Lewis M, Phillips C, et al. Strong HER-2/neu protein overexpression by immunohistoehemistry often does not predict oncogene amplification by fluorescence in situ hybridizalion [J]. Hum Pathol, 2005,36: 1043-1047.
5Gupta D, Middlelon L P, Whitaker M J, et al. Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene in breast caneer [J]. Am J Clin Pathol, 2003. 119: 381-387.
2Press MF,Bernstein L,Thomas PA,et al.HER-2/neu gene amplification characterized by fluorescence in situ hybridization:poor prognosis in node-negative breast carcinomas.J Clin Oncol,1997,15:2894-2904.
3Ratclitte N,Wells W,Wheeler K,et al.The combination of in situ hybridization and immunohistochemical analysis:an evaluation of HER-2/neu expression in paraffin-embedded breast carcinomas and adjacent normal-appearing breast epithelium.Mod Pathol,1997,10:1247-1252.
4Tanner M,Gancberg D,DiLeo A,et al.Chromogenic in situ hybridization:a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples.Am J Pathol,2000,157:1467-1472.
5Zhao JX,Wu R,Au A,et al.Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma.Mod Pathol,2002,15:657-665.
6Gupta D,Middleton LP,Whitaker MJ,et al.Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene in braest cancer.Am J Clin Pathol,2003,119:381-387.
7Van de Vijver MJ. Assessment of the need and appropriate method for testing for the human epidermal growth factor receptor-2 (HER2).Eur J Cancer, 2001, 37Suppl 1: 11-17.
8Ross JS, Gray GS. Targeted therapy for cancer: the HER-2/neu and Herceptin story. Clin Leadersh Manag Rev, 2003, 17:333-340.
9Vogel-C, Cobieigh MA, Tripathy D? et al. First-line, single-agent Herceptin ( R ) ( trastuzumab ) in metastatic breast cancer: a preliminary report. Eur J Cancer, 2001, 37 Suppl 1:25-29.
10Hammock L, Lewis M, Phillips C, et al. Strong Her-2/neu protein overexpression by immunohistochemistry often does not predict oncogene amplification by fluorescence in situ hybridization. Hum Pathol, 2005,36 : 1043-1047.
